[HTML][HTML] Pharmacogenomics of hypertension treatment

J Rysz, B Franczyk, M Rysz-Górzyńska… - International journal of …, 2020 - mdpi.com
Hypertension is one of the strongest modifiable cardiovascular risk factors, affecting an
increasing number of people worldwide. Apart from poor medication adherence, the low …

[HTML][HTML] Antihypertensives associated adverse events: a review of mechanisms and pharmacogenomic biomarkers available evidence in multi-ethnic populations

SM Altoum, ZN Al-Mahayri, BR Ali - Frontiers in Pharmacology, 2023 - frontiersin.org
Hypertension remains a significant health burden worldwide, re-emphasizing the
outstanding need for more effective and safer antihypertensive therapeutic approaches …

[HTML][HTML] Genetic variants for personalised management of very low carbohydrate ketogenic diets

L Aronica, J Volek, A Poff… - BMJ Nutrition, Prevention …, 2020 - ncbi.nlm.nih.gov
The ketogenic diet (KD) is a low-carbohydrate, high-fat, adequate-protein diet proven to be
effective for the reversal of obesity, metabolic syndrome and type 2 diabetes, and holding …

[HTML][HTML] Pharmacogenomics of amlodipine and hydrochlorothiazide therapy and the quest for improved control of hypertension: a mini review

R Johnson, P Dludla, S Mabhida, M Benjeddou… - Heart failure …, 2019 - Springer
Blood pressure (BP) is a complex trait that is regulated by multiple physiological pathways
and include but is not limited to extracellular fluid volume homeostasis, cardiac contractility …

[HTML][HTML] Influence of genetic west African ancestry on metabolomics among hypertensive patients

M Mehanna, CW McDonough, SM Smith, Y Gong… - Metabolites, 2022 - mdpi.com
Patients with higher genetic West African ancestry (GWAA) have hypertension (HTN) that is
more difficult to treat and have higher rates of cardiovascular diseases (CVD) and differential …

[HTML][HTML] Dapagliflozin mediates Plin5/PPARα signaling axis to attenuate cardiac hypertrophy

J Yu, H Zhao, X Qi, L Wei, Z Li, C Li, X Zhang… - Frontiers in …, 2021 - frontiersin.org
Objective: The purpose of this study was to investigate the effect of dapagliflozin (DAPA), a
sodium-glucose cotransporter 2 inhibitor, on relieving cardiac hypertrophy and its potential …

Genomic association analysis reveals variants associated with blood pressure response to beta‐blockers in European Americans

S Singh, N El Rouby, CW McDonough… - Clinical and …, 2019 - Wiley Online Library
European Americans (EA) have a better antihypertensive response to β‐blockers when
compared with African Americans, albeit with some variability. We undertook a genomewide …

[HTML][HTML] Exploration of CYP21A2 and CYP17A1 polymorphisms and preeclampsia risk among Chinese Han population: a large-scale case-control study based on …

B Hou, X Jia, Z Deng, X Liu, H Liu, H Yu, S Liu - Human Genomics, 2020 - Springer
Background Several genome-wide association studies have identified single-nucleotide
polymorphisms (SNPs), such as rs4409766, rs1004467, and rs3824755 in CYP17A1 and …

[HTML][HTML] Genetic contributors of efficacy and adverse metabolic effects of chlorthalidone in African Americans from the genetics of hypertension associated treatments …

ND Armstrong, V Srinivasasainagendra, LMS Chekka… - Genes, 2022 - mdpi.com
Hypertension is a leading risk factor for cardiovascular disease mortality. African Americans
(AAs) have the highest prevalence of hypertension in the United States, and to alleviate the …

[HTML][HTML] Genome wide analysis approach suggests chromosome 2 locus to be associated with thiazide and thiazide like-diuretics blood pressure response

S Singh, CW McDonough, Y Gong, KR Bailey… - Scientific reports, 2019 - nature.com
Chlorthalidone (CTD) is more potent than hydrochlorothiazide (HCTZ) in reducing blood
pressure (BP) in hypertensive patients, though both are plagued with BP response …